Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression

Brain, Behavior, and Immunity

Volumn 56, Issue , 2016, Pages 335-342

  Young, Kymberly D ^a   Drevets, Wayne C ^c   Dantzer, Robert ^d   Teague, T Kent ^e,f,g   Bodurka, Jerzy ^a,h   Savitz, Jonathan ^a,b  

^a LAUREATE INSTITUTE FOR BRAIN RESEARCH   (United States)

^b UNIVERSITY OF TULSA   (United States)

^c JOHNSON AND JOHNSON   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e University of Oklahoma Tulsa College of Medicine   (United States)

^f UNIVERSITY OF OKLAHOMA COLLEGE OF PHARMACY   (United States)

^g OKLAHOMA STATE UNIVERSITY   (United States)

^h UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Hippocampus; Magnetic resonance imaging; Major depressive disorder; Memory; Quinolinic acid

Indexed keywords

3 HYDROXYKYNURENINE; C REACTIVE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; KYNURENIC ACID; KYNURENINE; QUINOLINIC ACID; TUMOR NECROSIS FACTOR ALPHA; 3-HYDROXYKYNURENINE;

ADULT; ARTICLE; AUTOBIOGRAPHICAL MEMORY; BRAIN FUNCTION; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; EMOTIONALITY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; LEFT HEMISPHERE; MAJOR DEPRESSION; MALE; MENTAL PERFORMANCE; METABOLITE; PRIORITY JOURNAL; RECALL; ANALOGS AND DERIVATIVES; BLOOD; DIAGNOSTIC IMAGING; EPISODIC MEMORY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADULT; DEPRESSIVE DISORDER, MAJOR; FEMALE; HIPPOCAMPUS; HUMANS; KYNURENIC ACID; KYNURENINE; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, EPISODIC; MENTAL RECALL; MIDDLE AGED; QUINOLINIC ACID; YOUNG ADULT;

EID: 84964612382     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.04.007     Document Type: Article

References (60)

1. (APA), A.P.A. Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington, DC, Text Revision. fourth ed.
2. Agudelo L.Z., Femenia T., Orhan F., Porsmyr-Palmertz M., Goiny M., Martinez-Redondo V., Correia J.C., Izadi M., Bhat M., Schuppe-Koistinen I., Pettersson A.T., Ferreira D.M., Krook A., Barres R., Zierath J.R., Erhardt S., Lindskog M., Ruas J.L. Skeletal muscle PGC-1alpha1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell 2014, 159:33-45.
3. Andre C., O'Connor J.C., Kelley K.W., Lestage J., Dantzer R., Castanon N. Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration. J. Neuroimmunol. 2008, 200:90-99.
4. Arie M., Apter A., Orbach I., Yefet Y., Zalsman G. Autobiographical memory, interpersonal problem solving, and suicidal behavior in adolescent inpatients. Compr. Psychiatry 2008, 49:22-29.
5. Balosso S., Maroso M., Sanchez-Alavez M., Ravizza T., Frasca A., Bartfai T., Vezzani A. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain 2008, 131:3256-3265.
6. Bangen K.J., Restom K., Liu T.T., Wierenga C.E., Jak A.J., Salmon D.P., Bondi M.W. Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study. J. Alzheimers Dis. 2012, 31(Suppl 3):S59-S74.
7. Barrientos R.M., Frank M.G., Hein A.M., Higgins E.A., Watkins L.R., Rudy J.W., Maier S.F. Time course of hippocampal IL-1 beta and memory consolidation impairments in aging rats following peripheral infection. Brain Behav. Immun. 2009, 23:46-54.
8. Bay-Richter C., Linderholm K.R., Lim C.K., Samuelsson M., Traskman-Bendz L., Guillemin G.J., Erhardt S., Brundin L. A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality. Brain Behav. Immun. 2015, 43:110-117.
9. Black C., Miller B.J. Meta-analysis of cytokines and chemokines in suicidality: distinguishing suicidal versus nonsuicidal patients. Biol. Psychiatry 2015, 78:28-37.
10. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
11. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctot K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
12. Erhardt S., Lim C.K., Linderholm K.R., Janelidze S., Lindqvist D., Samuelsson M., Lundberg K., Postolache T.T., Traskman-Bendz L., Guillemin G.J., Brundin L. Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology 2013, 38:743-752.
13. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) 2002, New York State Psychiatric Institute, Biometrics Research, New York, NY.
14. Fleisher A.S., Podraza K.M., Bangen K.J., Taylor C., Sherzai A., Sidhar K., Liu T.T., Dale A.M., Buxton R.B. Cerebral perfusion and oxygenation differences in Alzheimer's disease risk. Neurobiol. Aging 2009, 30:1737-1748.
15. Fukui S., Schwarcz R., Rapoport S.I., Takada Y., Smith Q.R. Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J. Neurochem. 1991, 56:2007-2017.
16. Gibertini M., Newton C., Friedman H., Klein T.W. Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta. Brain Behav. Immun. 1995, 9:113-128.
17. Goldsmith D.R., Rapaport M.H., Miller B.J. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol. Psychiatry 2016.
18. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
19. Harrison N.A., Doeller C.F., Voon V., Burgess N., Critchley H.D. Peripheral inflammation acutely impairs human spatial memory via actions on medial temporal lobe glucose metabolism. Biol. Psychiatry 2014, 76:585-593.
20. Heisler J.M., O'Connor J.C. Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory. Brain Behav. Immun. 2015.
21. Hermans D., Defranc A., Raes F., Williams J.M., Eelen P. Reduced autobiographical memory specificity as an avoidant coping style. Br. J. Clin. Psychol. 2005, 44:583-589.
22. Hiles S.A., Baker A.L., de Malmanche T., Attia J. A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity. Brain Behav. Immun. 2012, 26:1180-1188.
23. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Med. 2009, 71:171-186.
24. Kawakami R., Shinohara Y., Kato Y., Sugiyama H., Shigemoto R., Ito I. Asymmetrical allocation of NMDA receptor epsilon2 subunits in hippocampal circuitry. Science 2003, 300:990-994.
25. Levine J., Barak Y., Chengappa K.N., Rapoport A., Rebey M., Barak V. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 1999, 40:171-176.
26. Lindqvist D., Janelidze S., Hagell P., Erhardt S., Samuelsson M., Minthon L., Hansson O., Bjorkqvist M., Traskman-Bendz L., Brundin L. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol. Psychiatry 2009, 66:287-292.
27. Liu Y., Wong T.P., Aarts M., Rooyakkers A., Liu L., Lai T.W., Wu D.C., Lu J., Tymianski M., Craig A.M., Wang Y.T. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 2007, 27:2846-2857.
28. Mathews A., MacLeod C. Cognitive vulnerability to emotional disorders. Annu. Rev. Clin. Psychol. 2005, 1:167-195.
29. Maxwell E. Family Interview for Genetic Studies (FIGS): A Manual for FIGS 1992, Clinical Neurogenetics Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD.
30. Navarro S.L., Brasky T.M., Schwarz Y., Song X., Wang C.Y., Kristal A.R., Kratz M., White E., Lampe J.W. Reliability of serum biomarkers of inflammation from repeated measures in healthy individuals. Cancer Epidemiol. Biomarkers Prev. 2012, 21:1167-1170.
31. Oitzl M.S., van Oers H., Schobitz B., de Kloet E.R. Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning. Brain Res. 1993, 613:160-163.
32. Palin K., Bluthe R.M., Verrier D., Tridon V., Dantzer R., Lestage J. Interleukin-1beta mediates the memory impairment associated with a delayed type hypersensitivity response to bacillus Calmette-Guerin in the rat hippocampus. Brain Behav. Immun. 2004, 18:223-230.
33. Pandey G.N., Rizavi H.S., Ren X., Fareed J., Hoppensteadt D.A., Roberts R.C., Conley R.R., Dwivedi Y. Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J. Psychiatr. Res. 2012, 46:57-63.
34. Pocivavsek A., Wu H.Q., Potter M.C., Elmer G.I., Pellicciari R., Schwarcz R. Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory. Neuropsychopharmacology 2011, 36:2357-2367.
35. Potter M.C., Elmer G.I., Bergeron R., Albuquerque E.X., Guidetti P., Wu H.Q., Schwarcz R. Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior. Neuropsychopharmacology 2010, 35:1734-1742. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology.
36. Price J.L., Drevets W.C. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010, 35:192-216.
37. Raison C.L., Miller A.H. Do cytokines really sing the blues?. Cerebrum: the Dana Forum on Brain Science 2013 2013, 10.
38. Rao J.S., Harry G.J., Rapoport S.I., Kim H.W. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol. Psychiatry 2010, 15:384-392.
39. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 2001, 58:445-452.
40. Richard-Devantoy S., Berlim M.T., Jollant F. Suicidal behaviour and memory: a systematic review and meta-analysis. World J. Biol. Psychiatry 2014, 1-23.
41. Sanacora G., Treccani G., Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012, 62:63-77.
42. Savitz J., Dantzer R., Wurfel B.E., Victor T.A., Ford B.N., Bodurka J., Bellgowan P.S., Teague T.K., Drevets W.C. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder. Psychoneuroendocrinology 2015, 52:200-211.
43. Savitz J., Drevets W.C., Smith C.M., Victor T.A., Wurfel B.E., Bellgowan P.S., Bodurka J., Teague T.K., Dantzer R. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder. Neuropsychopharmacology 2015, 40:463-471.
44. Savitz J., Drevets W.C., Wurfel B.E., Ford B.N., Bellgowan P.S., Victor T.A., Bodurka J., Teague T.K., Dantzer R. Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder. Brain Behav. Immun. 2015, 46:55-59.
45. Schwarcz R., Bruno J.P., Muchowski P.J., Wu H.Q. Kynurenines in the mammalian brain: when physiology meets pathology. Nat. Rev. Neurosci. 2012, 13:465-477.
46. Shinohara Y., Hirase H., Watanabe M., Itakura M., Takahashi M., Shigemoto R. Left-right asymmetry of the hippocampal synapses with differential subunit allocation of glutamate receptors. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19498-19503.
47. Stone T.W., Stoy N., Darlington L.G. An expanding range of targets for kynurenine metabolites of tryptophan. Trends Pharmacol. Sci. 2013, 34:136-143.
48. Talairach J., Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System - An Approach to Cerebral Imaging 1988, Thieme Medical Publishers, New York.
49. Videbech P., Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am. J. Psychiatry 2004, 161:1957-1966.
50. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M.M., Bartfai T., Binaglia M., Corsini E., Di Luca M., Galli C.L., Marinovich M. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 2003, 23:8692-8700.
51. Whiteford H.A., Degenhardt L., Rehm J., Baxter A.J., Ferrari A.J., Erskine H.E., Charlson F.J., Norman R.E., Flaxman A.D., Johns N., Burstein R., Murray C.J., Vos T. Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet 2013, 382:1575-1586.
52. Williams J.M., Barnhofer T., Crane C., Herman D., Raes F., Watkins E., Dalgleish T. Autobiographical memory specificity and emotional disorder. Psychol. Bull. 2007, 133:122-148.
53. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 2011, 25:181-213.
54. Young K., Bellgowan P., Bodurka J., Drevets W. Neurophysiological correlates of autobiographical memory deficits in currently and formerly depressed subjects. Psychol. Med. 2014, 44:2951-2963.
55. Young K., Bellgowan P., Bodurka J., Drevets W.C. Behavioral and neurophysiological correlates of autobiographical memory deficits in patients with depression and individuals at high risk for depression. J. Am. Med. Assoc. Psychiatry 2013, 70:698-708.
56. Young K.D., Bellgowan P.S., Bodurka J., Drevets W.C. Behavioral and neurophysiological correlates of autobiographical memory deficits in patients with depression and individuals at high risk for depression. JAMA Psychiatry 2013, 70:698-708.
57. Young K.D., Bellgowan P.S., Bodurka J., Drevets W.C. Neurophysiological correlates of autobiographical memory deficits in currently and formerly depressed subjects. Psychol. Med. 2014, 44:2951-2963.
58. Young K.D., Erickson K., Nugent A.C., Fromm S.J., Mallinger A.G., Furey M.L., Drevets W.C. Functional anatomy of autobiographical memory recall deficits in depression. Psychol. Med. 2012, 42:345-357.
59. Zunszain P.A., Anacker C., Cattaneo A., Choudhury S., Musaelyan K., Myint A.M., Thuret S., Price J., Pariante C.M. Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology 2012, 37:939-949. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology.
60. Zwilling D., Huang S.Y., Sathyasaikumar K.V., Notarangelo F.M., Guidetti P., Wu H.Q., Lee J., Truong J., Andrews-Zwilling Y., Hsieh E.W., Louie J.Y., Wu T., Scearce-Levie K., Patrick C., Adame A., Giorgini F., Moussaoui S., Laue G., Rassoulpour A., Flik G., Huang Y., Muchowski J.M., Masliah E., Schwarcz R., Muchowski P.J. Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. Cell 2011, 145:863-874.